Deferred Tax Assets, Gross of Co-Diagnostics, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
Co-Diagnostics, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $22,078,233, a 45% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Gross, Quarterly (USD)

Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$22,078,233	+$6,812,334	+45%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$15,265,899	+$10,121,684	+197%	31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2022	$5,144,215	+$4,584,294	+819%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$559,921	-$342,679	-38%	31 Dec 2021	10-K	16 Mar 2023	2022	FY
Q4 2020	$902,600	-$4,258,900	-83%	31 Dec 2020	10-K	24 Mar 2022	2021	FY
Q4 2019	$5,161,500			31 Dec 2019	10-K	25 Mar 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.